Onkolojik Hastalarda İnternal Jügüler Ven Yoluyla Venöz Port Implantasyonu- Tek Bir Genel Cerrahın Deneyimi

Abstract

Central venous access is pivotal for patients undergoing repetitive chemotherapy, hemodialysis, blood transfusions, total parenteral nutrition, and blood tests. This study aims to present the single-center experience of a general surgeon in Totally Implantable Access Port (TIAP) implantation under general anesthesia using ultrasonography and fluoroscopy guidance and assess early and late complications. A retrospective study was conducted on patients who underwent TIAP implantation between January 2020 and December 2022. Patients eligible for intravenous chemotherapy with solid tumors were included. A single general surgeon performed the procedures. General anesthesia was administered in all patients, and a percutaneous Seldinger technique was utilized. Early and late complications were monitored, and relevant data were collected. The study comprised 186 patients with a median age of 46, predominantly female (65.1%). The overall success rate was 99.5%. Early and late complications occurred in 1.6% and 5.9% of cases. The most common late complications were pocket infection (1.6%) and symptomatic thrombosis (1.6%). Port migration occurred in one patient but was promptly corrected. No pneumothorax cases were observed. Port removal was performed in 92 patients upon chemotherapy completion. Implantation of TIAPs under general anesthesia, guided by ultrasound and fluoroscopy, resulted in a high success rate and low complication rate when performed by a skilled general surgeon. These findings underscore the safety and efficacy of TIAP implantation under general anesthesia in a private hospital setting. The study contributes to the growing body of evidence supporting general surgeons in providing effective and safe TIAP implantation for oncology patients, potentially expanding its availability in diverse clinical settings.